Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| CANF (Can-Fite BioPharma Ltd.) | -22.25% | -85.86% | -62.33% | -62.44% | NA | NA | NA | … | … |
Data as of 06/03/2026, Common starting date is 09/03/2020
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| CANF (Can-Fite BioPharma Ltd.) | 09/03/2020 | 06/03/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -7.16 | -85.86 | -62.33 | -62.44 | NA | NA | NA | … | … | -22.25 | -87.65 | -26.36 | -63.93 | -52.71 | -27.53 | -1.11 |
| Sharpe Ratio | NA | -1.00 | -0.78 | -0.82 | NA | NA | NA | … | … | -0.44 | -1.06 | -0.39 | -0.96 | -0.85 | -0.29 | -0.06 |
| Standard Deviation(%) | NA | 87.34 | 78.30 | 78.85 | NA | NA | NA | … | … | 86.59 | 85.90 | 76.05 | 70.69 | 63.97 | 93.70 | 61.39 |
| Draw Down(%) | NA | 87.24 | 96.77 | 99.41 | NA | NA | NA | … | … | 51.66 | 91.58 | 70.44 | 75.04 | 58.62 | 66.44 | 22.79 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/03/2026, Common starting date is 09/03/2020
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| CANF (Can-Fite BioPharma Ltd.) |
-67.99%
Dec 2022 – Dec 2025 |
-63.73%
Mar 2021 – Mar 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| CANF (Can-Fite BioPharma Ltd.) |
-43.19%
Nov 2021 – Nov 2024 |
-52.46%
Oct 2020 – Oct 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart